Healthcare - Biotechnology - NASDAQ - US
$ 1.54
-8.33 %
$ 103 M
Market Cap
-0.77
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--2.21%
EBIT
Estimate
19.27%
Net Income
Estimate
18.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Generation Bio Co.
GBIO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GBIO
EBIT FORECAST
EBIT Forecast Chart GBIO
NET INCOME FORECAST
Net Income Chart GBIO